Information Provided By:
Fly News Breaks for November 16, 2015
CEMP
Nov 16, 2015 | 08:33 EDT
As previously reported, Morgan Stanley upgraded Cempra to Overweight from Equal Weight and increased its price target to $38 from $25 on shares. Analyst Andrew Byrnes said recently released additional details on the solithromycin IV data from the Solitaire-IV trial that suggests approval is likely.
News For CEMP From the Last 2 Days
There are no results for your query CEMP